🇺🇸 FDA
Pipeline program

0.1% bromfenac

2018KYPJ101

Approved small_molecule completed

Quick answer

0.1% bromfenac for Pterygium is a Approved program (small_molecule) at Zhongshan Ophthalmic Center, Sun Yat-sen University with 1 ClinicalTrials.gov record(s).

Program details

Company
Zhongshan Ophthalmic Center, Sun Yat-sen University
Indication
Pterygium
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials